Which Antiplatelet Therapy for Which Patient? Dr. Thomas Cuisset

More articles by this author

Chronic Cerebrospinal Venous Insufficiency (CCSVI): Diagnosis and Management Marjeta Zorc, MD

Chronic Cerebrospinal Venous Insufficiency (CCSVI): Diagnosis and Management Marjeta Zorc, MD

Left Atrial Appendage Closure: Still under fire? Mayra Guerrero, MD

Left Atrial Appendage Closure: Still under fire? Mayra Guerrero, MD

Recent Advances in the Evaluation of the TAVI Candidate Alfonso Medina, MD

Recent Advances in the Evaluation of the TAVI Candidate Alfonso Medina, MD

Bleeding Risk Estimation and the New (BARC) Definition of Bleeding Events Dr. Franz Weidinger

Bleeding Risk Estimation and the New (BARC) Definition of Bleeding Events Dr. Franz Weidinger

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Rolling Stone: Registry of Intravascular Lithotripsy vs Atherectomy Use in Complex Calcified Lesions

Severe coronary calcification represents one of the main challenges in performing percutaneous coronary intervention, both due to the higher risk of stent underexpansion and...

Can TAVI Be Safely Performed in Patients With Bicuspid Aortic Valve?

Bicuspid aortic valve (BAV) represents an anatomical challenge for transcatheter aortic valve replacement (TAVR) due to the frequent presence of elliptical annuli, fibroc calcific...

FFR Assessment for the Selection of Hypertensive Patients Who Benefit from Renal Stenting

Atherosclerotic renal artery stenosis (ARAS) represents one of the main causes of secondary hypertension (HTN) and is associated with a higher risk of renal...